Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

MSF protests at International AIDS Conference asking for price reduction for CAB-LA and LEN-LA.
Press release
Press release |
17 October 2024
Diagnostics

‘Time for $5’ campaign to deliver 206,937 signatures to US corporation Danaher in Washington, DC, demanding a $5 price for their medical tests

4 min
Vaishnavi, a 7-year-old DRTB (Drug Resistant​ Tuberculosis) patient interacts with Prachi, an MSF nurse as her mother Vishaka holds her.​ Photograph by Prem Hessenkamp
Press release
Press release |
15 October 2024
Tuberculosis

MSF calls for urgent action as governments and donors are failing children with TB

4 min
Insulin pens, provided by MSF to diabetes type I patients below 15 years old. Photo credit: Jinane Saad/MSF
Press release
Press release |
26 September 2024
Diabetes

MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens

5 min
o diagnose all bacterial diseases which are affected children. The laboratory also includes a blood bank. In 2013, more than 1,600 bags had been collected of which 16% provided by volunteer donors. On 14 June 2014, MSF organized, in partnership with the Ministry of Health, various promotional activities to promote voluntary blood donation, on the occasion of the World Blood Donor Day. Photograph by Aurelie Baumel
Press release
Press release |
25 September 2024
Antimicrobial resistance

UN Political Declaration on antimicrobial resistance essential step, but concrete action from governments now critical

6 min
A close-up of Siwar holding her insulin pen. Siwar has type 1 diabetes and received her insulin pen from the MSF clinic in Arsal. Drawing on Siwar's experience, her father explains to how insulin pens make life easier for diabetic kids. Photo credit: Carmen Yahchouchi/MSF
Press release
Press release |
23 September 2024
Diabetes

Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible

4 min
The endTB trial results will be presented at the Union World Conference, 15-18 November 2023, in Paris, France. Photo credit: Siddharth Singh
Press release
Press release |
20 August 2024
Tuberculosis

Major advance in the fight against MDR-TB: four new short and effective treatments from independent clinical trials approved by the WHO

5 min
Augustin Mudiayi Photo credit: Augustin Mudiayi
Press release
Press release |
16 August 2024
Pandemic preparedness

MSF responds to WHO declaring mpox a public health emergency of international concern

3 min
Mr and Ms Kimboi, both of whom are HIV-positive, at the MSF Chakpikarong clinic. They’ve come to the clinic for a check-up and to collect their medication. MSF started providing specialised care for HIV and TB in Manipur in 2005 and 2007, respectively. Photograph by Jan-Joseph Stok
Press release
Press release |
26 July 2024
HIV/AIDS

Pharmaceutical corporation ViiV must urgently supply HIV drug CAB-LA according to global public health needs

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury